Abeona Therapeutics Appoints Dr. Victor Paulus Senior Vice President of Regulatory Affairs
(WorldNews Health)

NEW YORK and CLEVELAND, June 26, 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced the appointment of Victor Paulus, Ph.D. as Senior Vice President, Regulatory Affairs. The Company also announced the appointment of Jodie Gillon, M.P.H. as Vice President of Patient Advocacy and Clinical Affairs. Both Dr. Paulus and Ms. Gillon are reporting to Chief Executive Officer João Siffert, M.D. `The addition of these seasoned industry leaders will strengthen our relationships with key stakeholders toward the successful development of our therapies,` said Dr. Siffert. `Victor will lead us through the evolving regulatory...